8-K - Amylyx Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On March 3, 2026, Amylyx Pharmaceuticals, Inc. (the “Company”) issued a press release announcing its financial re

Financial Results

9.01

Financial Statements and Exhibits (d) Exhibits . Exhibit Number Description 99.1 Press Release of the Company, dated March 3, 2026 104 Cover Page Interactive Da

Exhibits Only

Exhibits (2)

8-K

99.1

EX-99.1